An adverse reaction to buprenorphine/naloxone induction in prison: A case report

Authors

Josiah D. Rich, The Warren Alpert Medical School
McKenzie, The Warren Alpert Medical School
Samuel Dickman, The Warren Alpert Medical School
Jeffrey Bratberg, University of Rhode Island
Joshua D. Lee, New York University
Robert P. Schwartz, Friends Research Institute, Inc.

Document Type

Article

Date of Original Version

12-1-2011

Abstract

Buprenorphine is an effective treatment for opiate dependence. Prisoners with histories of opiate dependence who are inducted on buprenorphine prior to release are at decreased risk of post-release relapse and overdose, yet many clinicians are unaware of the risks related to buprenorphine induction for non-opiate tolerant patients, especially those on other psychotropic medications. The authors report a case of probable non-lethal overdose during dose induction of a non-tolerant prisoner and discuss appropriate dosing under similar circumstances. Copyright © 2011 by Lippincott Williams & Wilkins.

Publication Title, e.g., Journal

Addictive Disorders and their Treatment

Volume

10

Issue

4

Citation/Publisher Attribution

Rich, Josiah D., McKenzie, Samuel Dickman, Jeffrey Bratberg, Joshua D. Lee, and Robert P. Schwartz. "An adverse reaction to buprenorphine/naloxone induction in prison: A case report." Addictive Disorders and their Treatment 10, 4 (2011): 199-200. doi: 10.1097/ADT.0b013e3182133949.